Kinnevik’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Kinnevik's RXRX Position: Q3 2025 in Review
Kinnevik held its Recursion Pharmaceuticals (RXRX) position steady in Q3 2025 at 13,434,171 shares worth $65.6M. The position accounts for 100% of the portfolio, ranked #1.
Kinnevik first reported a position in RXRX in Q4 2022 and has held it in 12 quarters since. The position peaked at $104M in Q1 2024. 326 funds tracked by Wall St. Rank hold RXRX as of Q3 2025.
- Kinnevik held 13,434,171 shares of Recursion Pharmaceuticals worth $65.6M as of Q3 2025.
- Kinnevik left its Recursion Pharmaceuticals share count unchanged in Q3 2025.
- Recursion Pharmaceuticals made up 100% of Kinnevik's portfolio in Q3 2025, its #1 holding.
- Kinnevik first reported a position in Recursion Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
- Kinnevik's Recursion Pharmaceuticals position peaked at $104M in Q1 2024.
- 326 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2025.
Based on Kinnevik's 13F filing for Q3 2025, filed 4 Nov 2025.